Impact of Intravenous Lidocaine During Colorectal Surgery on Pain and Immune Functions
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This study evaluates the impact of intraoperative intravenous lidocaine administered during
laparoscopic colorectal surgery on the intraoperative remifentanil consumption as well as
postoperative pain and opioid requirements. It will evaluate immune cell activity for 48hours
after surgical stress and general anesthesia with or without intravenous lidocaine.
Phase:
Phase 4
Details
Lead Sponsor:
Ciusss de L'Est de l'Île de Montréal
Collaborator:
Foundation of Anesthesia and Resuscitation of Quebec